Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective study

OBJECTIVE: We evaluated the efficacy and safety of transarterial chemoembolization (TACE) combined with apatinib plus PD-1 inhibitors (TACE-AP) compared with TACE combined with apatinib (TACE-A) in patients with advanced hepatocellular carcinoma (HCC) and to explore the prognostic factors affecting...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Wei-Li, Zhao, Xiao-Hui, Guo, Yuan-, Cao, Guang-Shao, Wu, Gang, Fan, Wei-Jun, Yao, Quan-Jun, Xu, Shi-Jun, Guo, Chen-Yang, Hu, Hong-Tao, Li, Hai-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562990/
https://www.ncbi.nlm.nih.gov/pubmed/36249011
http://dx.doi.org/10.3389/fonc.2022.961394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562990/
https://www.ncbi.nlm.nih.gov/pubmed/36249011
http://dx.doi.org/10.3389/fonc.2022.961394

Ejemplares similares